Sunflower Pharmaceutical Group Co.,Ltd.’s Net Profit Rose 20.2% in First Half of 2022

Sunflower Pharmaceutical Group Co.,Ltd. (葵花药业集团股份有限公司) (002737.SZ) reported a net profit of 425.6 million yuan in the first half of 2022, up 20.2% year-on-year.

Meanwhile, the company posted 2.2 billion yuan in revenue, up 7% year-on-year.

At the end of the reporting period, it had 5.6 billion yuan in total assets and 1.7 billion yuan in total liabilities, with a liability-to-asset ratio of 30.3%.